Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Irritable Bowel Syndrome, January 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 109 articles:
HTML format


 

Single Articles

  1. KHALIL TA, Filmban DM, Sinnah HNM, Fallatah RA, et al
    Knowledge, Attitude, and Practices Regarding the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome Among Primary Healthcare Physicians in Saudi Arabia.
    Cureus. 2023;15:e49460.
    PubMed    
    Abstract available

  2. HANSSEN HM, Fjellstad MS, Skjevling L, Johnsen PH, et al
    Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol.
    BMJ Open. 2023;13:e073242.
    PubMed    
    Abstract available

  3. ISAKOV VA, Pilipenko VI, Vlasova AV, Kochetkova AA, et al
    Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins for the Management of Constipation-Predominant Irritable Bowel Syndrome in Females: A Randomized Pilot Study.
    Curr Dev Nutr. 2023;7:102037.
    PubMed    
    Abstract available

  4. RUSU F, Caragut RL, Mocanu LC, Leucuta DC, et al
    Microscopic Colitis: A Diagnostic Challenge in Patients with Irritable Bowel Syndrome.
    J Gastrointestin Liver Dis. 2023;32:469-472.
    PubMed    
    Abstract available

  5. ALEXOUDI A, Kesidou L, Gatzonis S, Charalampopoulos C, et al
    Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
    Cureus. 2023;15:e49320.
    PubMed    
    Abstract available

  6. XIAO J, Zhou YN, Yang YL, He L, et al
    Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis.
    Front Pharmacol. 2023;14:1330698.
    PubMed    
    Abstract available

  7. ZHAO J, Tian L, Xia B, Mi N, et al
    Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study.
    Front Pharmacol. 2023;14:1244563.
    PubMed    
    Abstract available

  8. ALSHAARAWY O, Balasubramanian G, Venkatesan T
    Cannabis use in the United States and its impact on gastrointestinal health.
    Nutr Clin Pract. 2023 Dec 23. doi: 10.1002/ncp.11111.
    PubMed    
    Abstract available

  9. STAMATOPOULOS K, Mistry N, Fotaki N, Turner DB, et al
    Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor.
    Pharmaceutics. 2023;15:2726.
    PubMed    
    Abstract available

  10. MATIS L, Daina LG, Maris L, Ghitea TC, et al
    Variety of Serotonin Levels in Pediatric Gastrointestinal Disorders.
    Diagnostics (Basel). 2023;13:3675.
    PubMed    
    Abstract available

  11. AWAD K, Barmeyer C, Bojarski C, Nagel O, et al
    Epithelial Barrier Dysfunction in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) via Downregulation of Claudin-1.
    Cells. 2023;12:2846.
    PubMed    
    Abstract available

  12. YAMAMOTO K, Takada Y, Kobayashi T, Ito R, et al
    Rapid transformation of branched pancreatic duct-derived intraductal tubulopapillary neoplasm into an invasive carcinoma: A case report.
    World J Clin Oncol. 2023;14:620-627.
    PubMed    
    Abstract available

  13. GARGARI G, Mantegazza G, Cremon C, Taverniti V, et al
    Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome.
    Gut Microbes. 2024;16:2298246.
    PubMed    
    Abstract available

  14. BUCKLE RL, Brown LC, Aziz I
    Randomized trial in postprandial functional dyspepsia: Reassurance and diagnostic explanation with or without traditional dietary advice.
    Neurogastroenterol Motil. 2024 Jan 4:e14733. doi: 10.1111/nmo.14733.
    PubMed    
    Abstract available

  15. FELT K, Stauffer M, Salas-Estrada L, Guzzo PR, et al
    Structural basis for partial agonism in 5-HT(3A) receptors.
    Nat Struct Mol Biol. 2024 Jan 4. doi: 10.1038/s41594-023-01140.
    PubMed    
    Abstract available

  16. CHEN Y, Feng S, Li Y, Zhang C, et al
    Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.
    Immunology. 2024 Jan 4. doi: 10.1111/imm.13749.
    PubMed    
    Abstract available

  17. NILES SE, Blazy P, Cheuvront SN, Kenefick RW, et al
    Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study.
    World J Gastrointest Pharmacol Ther. 2023;14:39-49.
    PubMed    
    Abstract available

  18. CHAN ACY, Siah KTH
    Can Small Fiber Neuropathy Explain the Overlap Gastrointestinal and Non-gastrointestinal Symptoms in Some Irritable Bowel Syndrome Patients?
    J Neurogastroenterol Motil. 2024;30:116-118.
    PubMed    


  19. DEUTSCH D, Bouchoucha M, Uzan J, Airinei G, et al
    Relationship Between Colonic Transit Response to Eating With Self-reported Constipation Severity in Constipated Patients According to the Phenotype.
    J Neurogastroenterol Motil. 2024;30:97-105.
    PubMed    
    Abstract available

  20. CHANG YH, Choi YJ, Shin CM, Moon JS, et al
    Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
    J Neurogastroenterol Motil. 2024;30:73-86.
    PubMed    
    Abstract available

  21. CHEN F, Tan N, Chen S, Zhuang Q, et al
    The Disease Spectrum and Natural History of Patients With Abdominal Bloating or Distension: A Longitudinal Study.
    J Neurogastroenterol Motil. 2024;30:64-72.
    PubMed    
    Abstract available

  22. TAKAKURA W, Rezaie A, Chey WD, Wang J, et al
    Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2024;30:7-16.
    PubMed    
    Abstract available

  23. KIM YS, Oshima T, Siah KTH, Choi SC, et al
    Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice.
    J Neurogastroenterol Motil. 2024;30:4-6.
    PubMed    


  24. MASOOD R, Mandalia K, Pagani NR, Moverman MA, et al
    Functional somatic syndromes are associated with inferior outcomes and increased complications after hip and knee arthroplasty: a systematic review.
    Arthroplasty. 2024;6:2.
    PubMed    
    Abstract available

  25. TAYAMA J, Hamaguchi T, Koizumi K, Yamamura R, et al
    Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial.
    Sci Rep. 2024;14:4.
    PubMed    
    Abstract available

  26. MEYNIER M, Daugey V, Mallaret G, Gervason S, et al
    Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice.
    Gut Microbes. 2024;16:2298026.
    PubMed    
    Abstract available

  27. KATSUMATA R, Hosokawa T, Kamada T
    Artificial Intelligence-Based Diagnostic Support System for Functional Dyspepsia Based on Brain Activity and Food Preference.
    Cureus. 2023;15:e49877.
    PubMed    
    Abstract available

  28. KAZEMI A, Iraji A, Esmaealzadeh N, Salehi M, et al
    Peppermint and menthol: a review on their biochemistry, pharmacological activities, clinical applications, and safety considerations.
    Crit Rev Food Sci Nutr. 2024 Jan 3:1-26. doi: 10.1080/10408398.2023.2296991.
    PubMed    
    Abstract available

  29. XU M, Liu D, Tan Y, He J, et al
    A Mendelian randomization study on the effects of plasma lipids on irritable bowel syndrome and functional dyspepsia.
    Sci Rep. 2024;14:78.
    PubMed    
    Abstract available

  30. TU X, Ren H, Bu S
    Therapeutic effects of curcumin on constipation-predominant irritable bowel syndrome is associated with modulating gut microbiota and neurotransmitters.
    Front Microbiol. 2023;14:1274559.
    PubMed    
    Abstract available

  31. RAO X, Xing Y, Ji C, Guo J, et al
    Efficacy of moxibustion in diarrhea-predominant irritable bowel syndrome model rats: a systematic review and meta-analysis.
    Front Bioeng Biotechnol. 2023;11:1309661.
    PubMed    
    Abstract available

  32. JI Q, Du F, Yu Y, Li Y, et al
    Exploring the clinical significance of miR-148 expression variations in distinct subtypes of irritable bowel syndrome.
    Ann Hum Genet. 2023 Dec 31. doi: 10.1111/ahg.12543.
    PubMed    
    Abstract available

  33. SOLOVYEVA OI, Nekrasova AS, Topalova IG, Ponomarenko VA, et al
    [Long-term probiotic administration for irritable bowel syndrome: a legal need].
    Ter Arkh. 2023;95:679-685.
    PubMed    
    Abstract available

  34. MAKAROVA AA, Ruchkina IN, Diukova GM, Romashkina NV, et al
    [Drug therapy's new options in the treatment of the severe irritable bowel syndrome].
    Ter Arkh. 2023;95:627-633.
    PubMed    
    Abstract available

  35. FRISSORA CL, Schiller LR
    Getting the BS out of Irritable Bowel Syndrome with Diarrhea (IBS-D): Let's Make a Diagnosis.
    Curr Gastroenterol Rep. 2023 Dec 30. doi: 10.1007/s11894-023-00909.
    PubMed    
    Abstract available

  36. ZHANG Y, Qu Q, Lei X, Zhao X, et al
    Quality markers of Guchang Zhixie pills based on multicomponent qualitative and quantitative analysis combined with network pharmacology and chemometric analysis.
    J Pharm Biomed Anal. 2023;240:115934.
    PubMed    
    Abstract available

  37. RAY K
    Amitriptyline as second-line treatment for IBS in primary care settings.
    Nat Rev Gastroenterol Hepatol. 2024;21:2.
    PubMed    


  38. HUISMAN D, Burrows T, Sweeney L, Bannister K, et al
    'Symptom-free' when inflammatory bowel disease is in remission: Expectations raised by online resources.
    Patient Educ Couns. 2024;119:108034.
    PubMed    
    Abstract available

  39. BURNS GL, Potter M, Mathe A, Bruce J, et al
    TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional Dyspepsia.
    Clin Transl Gastroenterol. 2023;14:e00638.
    PubMed    
    Abstract available

  40. BERNARD J, Barnetche T, Amory C, Despres J, et al
    Frequency of irritable bowel syndrome in spondyloarthritis: a multicentric cross-sectional study and meta-analysis.
    RMD Open. 2024;10:e003836.
    PubMed    
    Abstract available

  41. EID NM, Alsolami GA, Al-Nuafie HD, Malibari HW, et al
    Assessment of Knowledge, Perception, and Practices Regarding Probiotics and Prebiotics Among Clinicians in Saudi Arabia: A Pilot Study.
    Cureus. 2024;16:e52080.
    PubMed    
    Abstract available

  42. DI LORENZO C, Khlevner J, Rodriguez-Araujo G, Xie W, et al
    Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2024 Jan 8:S2468-1253(23)00398.
    PubMed    
    Abstract available

  43. NAM Y, Kim KB, Kim SH, Park KH, et al
    Synergistic Integration of Machine Learning with Microstructure/Composition-Designed SnO(2) and WO(3) Breath Sensors.
    ACS Sens. 2024 Jan 11. doi: 10.1021/acssensors.3c01814.
    PubMed    
    Abstract available

  44. CHOI SI, Kim N, Nam RH, Jang JY, et al
    Erratum: The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model.
    J Cancer Prev. 2023;28:219.
    PubMed    
    Abstract available

  45. SCARPELLINI E, Balsiger LM, Broeders B, Houte KVD, et al
    Nutrition and Disorders of Gut-Brain Interaction.
    Nutrients. 2024;16:176.
    PubMed    
    Abstract available

  46. RODRIGUES JM, Ventura C, Abreu M, Santos C, et al
    Electro-Acupuncture Effects Measured by Functional Magnetic Resonance Imaging-A Systematic Review of Randomized Clinical Trials.
    Healthcare (Basel). 2023;12:2.
    PubMed    
    Abstract available

  47. KUMOLU-JOHNSON T, Senbanjo IO
    Prevalence and pattern of functional gastrointestinal disorders among secondary school adolescents in Lagos, Nigeria.
    J Trop Pediatr. 2023;70:fmad048.
    PubMed    
    Abstract available

  48. MA YY, Hao Z, Chen ZY, Shen YX, et al
    Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review.
    J Integr Med. 2023 Dec 23:S2095-4964(23)00098-5. doi: 10.1016/j.joim.2023.
    PubMed    
    Abstract available

  49. LI Z, Ma Q, Deng Y, Rolls ET, et al
    Irritable Bowel Syndrome is Associated with Brain Health by Neuroimaging, Behavioral, Biochemical, and Genetic Analyses.
    Biol Psychiatry. 2024 Jan 8:S0006-3223(24)00027.
    PubMed    
    Abstract available

  50. ZHANG M, Dang M, Li Y, Wei P, et al
    Natural products derived from herbs as promising source for diarrhea predominant-irritable bowel syndrome via gut microbiota-serotonin pathway.
    J Pharm Pharmacol. 2024 Jan 10:rgad120. doi: 10.1093.
    PubMed    
    Abstract available

  51. SHANSHAL SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN, et al
    Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Ceska Slov Farm. 2024;72:233-241.
    PubMed    
    Abstract available

  52. SHARBAFCHI MR, Afshar Zanjani H, Saneian Z, Feizi A, et al
    Effects of Duloxetine on Gastrointestinal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Patients with the Moderate-to-Severe Irritable Bowel Syndrome.
    Adv Biomed Res. 2023;12:249.
    PubMed    
    Abstract available

  53. HARPER AM, Watson J, O'Donnell R, Elwenspoek MM, et al
    Understanding the patient's experience of coeliac disease diagnosis: a qualitative interview study.
    Br J Gen Pract. 2024 Jan 8:BJGP.2023.0299. doi: 10.3399/BJGP.2023.0299.
    PubMed    
    Abstract available

  54. KADER L, Willits A, Meriano S, Christianson JA, et al
    Identification of arginine-vasopressin receptor 1a (Avpr1a/AVPR1A) as a novel candidate gene for chronic visceral pain.
    bioRxiv. 2023 Dec 19:2023.12.19.572390. doi: 10.1101/2023.12.19.572390.
    PubMed    
    Abstract available

  55. BAI W, Wang Z, Liang J, Deng H, et al
    Atractylodes macrocephala-Paeonia lactiflora Class Formula for the Treatment of Irritable Bowel Syndrome: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.
    Cureus. 2023;15:e49997.
    PubMed    
    Abstract available

  56. ROMANO A, Balestrini L, Della Scala G, Chico L, et al
    Effects of a Nutraceutical Multicompound, with Probiotics, Hericium, PEA, and Undaria in Patients with Irritable Bowel Syndrome.
    J Diet Suppl. 2024 Jan 8:1-11. doi: 10.1080/19390211.2023.2296106.
    PubMed    
    Abstract available

  57. SHANSHAL SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN, et al
    Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.
    Ceska Slov Farm. 2024;73:233-241.
    PubMed    
    Abstract available

  58. ZENG Y, Liu H, Pei Z, Li R, et al
    Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization.
    BMC Gastroenterol. 2024;24:19.
    PubMed    
    Abstract available

  59. FERREIRA J
    Deleting enkephalin and mimicking IBS in mice.
    Lab Anim (NY). 2024;53:5.
    PubMed    


  60. POPESKOU SG, Roesel R, Faes S, Vanoni A, et al
    Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized Study.
    Ann Surg. 2024;279:196-202.
    PubMed    
    Abstract available

  61. BERTANI L, Balestrini L, Chico L, Della Scala G, et al
    Specific probiotics and prebiotics to improve the quality of life of patients with chronic irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2024 Jan 19. doi: 10.23736/S2724-5985.23.03563.
    PubMed    
    Abstract available

  62. LIAO LM, Zou L, Li KW, Ruan JR, et al
    Moxibustion ameliorates visceral hypersensitivity by regulating hypothalamus-spinal cord-colon axis in rats with irritable bowel syndrome with diarrhea.
    Zhen Ci Yan Jiu. 2024;49:47-56.
    PubMed    
    Abstract available

  63. VON DEM KNESEBECK O, Lowe B, Ludecke D, Bobardt JS, et al
    Public knowledge and beliefs about the irritable bowel syndrome - results from the SOMA.SOC study.
    BMC Public Health. 2024;24:219.
    PubMed    
    Abstract available

  64. NIELSEN OH, Pardi DS
    Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care.
    Drugs Aging. 2024 Jan 17. doi: 10.1007/s40266-023-01094.
    PubMed    
    Abstract available

  65. SAROFIM M, Slaar A, Dermout S, den Boer F, et al
    Irritable bowel syndrome worsens faecal incontinence after primary repair of major obstetric anal sphincter injuries.
    Colorectal Dis. 2024 Jan 16. doi: 10.1111/codi.16862.
    PubMed    
    Abstract available

  66. COVELLO C, Becherucci G, Scaldaferri F, Laterza L, et al
    Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence.
    Pol Arch Intern Med. 2024 Jan 9:16659. doi: 10.20452/pamw.16659.
    PubMed    
    Abstract available

  67. ATZLER JJ, Crofton EC, Sahin AW, Ispiryan L, et al
    Effect of fibre fortification of low FODMAP pasta.
    Int J Food Sci Nutr. 2024 Jan 15:1-13. doi: 10.1080/09637486.2024.2303605.
    PubMed    
    Abstract available

  68. MOSGOELLER W, Muss C, Eisenwagen S, Jagsch R, et al
    [Zum Einsatz von PMA - Zeolith (Klinoptilolith) bei Patienten mit Reizdarmsyndrom - eine nicht-interventionelle Studie].
    Z Gastroenterol. 2024 Jan 15. doi: 10.1055/a-2223-3963.
    PubMed    
    Abstract available

  69. ACHARYA K, Bhardwaj V, Chuahan I, Mushfiq S, et al
    Comparison of Fecal Calprotectin with Different Endoscopic Scores in the Assessment of Ulcerative Colitis (UC) Activity and Its Utility in Differentiating IBS from IBD.
    Euroasian J Hepatogastroenterol. 2023;13:120-123.
    PubMed    
    Abstract available

  70. MANZA F, Lungaro L, Costanzini A, Caputo F, et al
    Gluten and Wheat in Women's Health: Beyond the Gut.
    Nutrients. 2024;16:322.
    PubMed    
    Abstract available

  71. SIU PLK, Choy CT, Chan HHY, Leung RKK, et al
    A Novel Multi-Strain E3 Probiotic Formula Improved the Gastrointestinal Symptoms and Quality of Life in Chinese Psoriasis Patients.
    Microorganisms. 2024;12:208.
    PubMed    
    Abstract available

  72. WAGNER LE, Bridges KM, Hinman JM, He J, et al
    Treatment of functional bowel disorders in an integrative medicine clinic resulting in improved digestive tract symptoms.
    JGH Open. 2024;8:e13022.
    PubMed    
    Abstract available

  73. WANG L, Luo X, Qing X, Fang S, et al
    Symptom effects and central mechanism of acupuncture in patients with functional gastrointestinal disorders: a systematic review based on fMRI studies.
    BMC Gastroenterol. 2024;24:47.
    PubMed    
    Abstract available

  74. BOYD T, Garcia-Fischer I, Silvernale C, Anyane-Yeboa A, et al
    Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Jan 23:e14742. doi: 10.1111/nmo.14742.
    PubMed    
    Abstract available

  75. ZHOU J, Wei H, Zhou A, Xiao X, et al
    The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    J Transl Med. 2024;22:98.
    PubMed    
    Abstract available

  76. YE XY, Chen JY, Wu LH, Luo DP, et al
    Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis.
    BMC Gastroenterol. 2024;24:45.
    PubMed    
    Abstract available

  77. SLOUHA E, Patel B, Mohamed A, Razeq Z, et al
    Psychotherapy for Irritable Bowel Syndrome: A Systematic Review.
    Cureus. 2023;15:e51003.
    PubMed    
    Abstract available

  78. ALCANTARA MONTERO A, Pacheco de Vasconcelos SR, Castro Arias A
    Contextualization of the concept of nociplastic pain in irritable bowel syndrome.
    Rev Esp Enferm Dig. 2024 Jan 23. doi: 10.17235/reed.2024.10186/2023.
    PubMed    
    Abstract available

  79. LASHGARI NA, Momeni Roudsari N, Momtaz S, Niazi Shahraki F, et al
    Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders.
    Curr Pharm Biotechnol. 2024 Jan 22. doi: 10.2174/0113892010261502231102040149.
    PubMed    
    Abstract available

  80. PASTA A, Formisano E, Calabrese F, Plaz Torres MC, et al
    Food Intolerances, Food Allergies and IBS: Lights and Shadows.
    Nutrients. 2024;16:265.
    PubMed    
    Abstract available

  81. ZYSK W, Mesjasz A, Trzeciak M, Horvath A, et al
    Gastrointestinal Comorbidities Associated with Atopic Dermatitis-A Narrative Review.
    Int J Mol Sci. 2024;25:1194.
    PubMed    
    Abstract available

  82. CUCIUREANU DI, Bistriceanu CE, Vulpoi GA, Cuciureanu T, et al
    Migraine Comorbidities.
    Life (Basel). 2024;14:74.
    PubMed    
    Abstract available

  83. LEE SB, Chae HW, Kwon JW, Sung S, et al
    Association of Functional Gastrointestinal Disorders with Adolescent Idiopathic Scoliosis.
    Children (Basel). 2024;11:118.
    PubMed    
    Abstract available

  84. CAI LL, Li X, Cai QH, Guo SX, et al
    Irritable bowel syndrome in children: the placebo response rate and influencing factors a meta-analysis.
    Pediatr Res. 2024 Jan 22. doi: 10.1038/s41390-023-02996.
    PubMed    
    Abstract available

  85. KING AJ, Chang L, Li Q, Liu L, et al
    NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.
    Am J Physiol Gastrointest Liver Physiol. 2024.
    PubMed    
    Abstract available

  86. HOJSAK I, Kolacek S
    Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children.
    Pediatr Gastroenterol Hepatol Nutr. 2024;27:1-14.
    PubMed    
    Abstract available

  87. ALSHAMMARI SA, Almutairi MN, Alomar MO, Alsherif ZM, et al
    Overlap Between Gastroesophageal Reflux Disease and Irritable Bowel Syndrome and Its Impact on Quality of Life.
    Cureus. 2023;15:e50840.
    PubMed    
    Abstract available

  88. IOANNOU P, Ziogou A, Giannakodimos I, Giannakodimos A, et al
    Infective Endocarditis by Lactobacillus Species-A Narrative Review.
    Antibiotics (Basel). 2024;13:53.
    PubMed    
    Abstract available

  89. FAN R, Zhang J, Shen J, Mao C, et al
    Causal Relationships of Chronic Constipation and Irritable Bowel Syndrome with Digestive Tract Cancers: A Mendelian Randomization Study.
    Recent Pat Anticancer Drug Discov. 2024.
    PubMed    
    Abstract available

  90. PRIEGO-PARRA BA, Triana-Romero A, Lajud-Barquin FA, de Fatima Higuera-DelaTijera M, et al
    Association of adverse childhood experiences with irritable bowel syndrome in Mexican adults: A cross-sectional study.
    Neurogastroenterol Motil. 2024 Jan 19:e14743. doi: 10.1111/nmo.14743.
    PubMed    
    Abstract available

  91. IRIBARREN C, Savolainen O, Sapnara M, Tornblom H, et al
    Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Jan 19:e14741. doi: 10.1111/nmo.14741.
    PubMed    
    Abstract available

  92. CHANG HC, Gau SY
    Letter: antibiotics prescription and new-onset irritable bowel syndrome.
    Aliment Pharmacol Ther. 2024;59:299.
    PubMed    


  93. STALLER K, Ludvigsson JF
    Letter: Irritable bowel syndrome and antibiotics-Authors' reply.
    Aliment Pharmacol Ther. 2024;59:422.
    PubMed    


  94. LONGSTRETH GF
    Letter: Irritable bowel syndrome and antibiotics.
    Aliment Pharmacol Ther. 2024;59:421.
    PubMed    


  95. BLACK CJ, Gracie DJ
    Editorial: A Mediterranean diet for IBS-Is healthy and inclusive eating the way forward?
    Aliment Pharmacol Ther. 2024;59:571-572.
    PubMed    



  96. American College of Gastroenterology Monograph on Microbiome Therapeutics.
    Am J Gastroenterol. 2024;119.
    PubMed    


  97. VAN TILBURG MAL, Rana H
    Well-Being of Patients With Irritable Bowel Syndrome: A Shift From Measuring Deficits to Strengths?
    Am J Gastroenterol. 2024 Jan 2. doi: 10.14309/ajg.0000000000002601.
    PubMed    


  98. LI F, Yano Y, Etievant L, Daniel CR, et al
    The Time-Dependent Association between Irritable Bowel Syndrome and All-cause and Cause-specific Mortality: A Prospective Cohort Study within the UK Biobank.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002675.
    PubMed    
    Abstract available

  99. ONG AM
    Take a Deep Breath and Keep Your Video On: Can Virtual Yoga Help IBS?
    Dig Dis Sci. 2024;69:10-12.
    PubMed    


  100. SHIHA MG, Aziz I
    Amitriptyline for the management of IBS in primary care.
    Gastroenterology. 2023 Dec 24:S0016-5085(23)05680.
    PubMed    
    Abstract available

  101. DECRAECKER L, De Looze D, Hirsch DP, De Schepper H, et al
    Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
    Gut. 2024 Jan 8:gutjnl-2023-331634. doi: 10.1136/gutjnl-2023-331634.
    PubMed    
    Abstract available

  102. KUMAR SE, Jaleel R, Varghese T, Praharaj I, et al
    Fecal calgranulin as a potential screening tool to differentiate inflammatory bowel disease from irritable bowel syndrome.
    Indian J Gastroenterol. 2024 Jan 23. doi: 10.1007/s12664-024-01525.
    PubMed    


  103. MATHUR A, Shams U, Mishra P, Sahu S, et al
    Post-infection irritable bowel syndrome following Coronavirus disease-19: A systematic review and meta-analysis.
    Indian J Gastroenterol. 2024 Jan 23. doi: 10.1007/s12664-023-01486.
    PubMed    
    Abstract available

  104. MARASCO G, Cremon C, Barbaro MR, Stanghellini V, et al
    Management of Irritable Bowel Syndrome With Diarrhea.
    J Clin Gastroenterol. 2024 Jan 15. doi: 10.1097/MCG.0000000000001964.
    PubMed    
    Abstract available

  105. SCHUBACH A, Quigley BM, Lackner JM, Gudleski GD, et al
    Somatization Mediates the Relationship Between Childhood Trauma and Pain Ratings in Patients with Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2024 Jan 25. doi: 10.1097/MCG.0000000000001974.
    PubMed    
    Abstract available

  106. CHUAH KH, Mahadeva S
    Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
    J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
    PubMed    


  107. KIM YJ, Lee SG, Lee JS, Choi YJ, et al
    Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.
    J Psychosom Res. 2024;177:111589.
    PubMed    
    Abstract available

  108. LEE KS, Song IS, Kim ES, Kim J, et al
    Machine learning analysis with population data for the associations of preterm birth with temporomandibular disorder and gastrointestinal diseases.
    PLoS One. 2024;19:e0296329.
    PubMed    
    Abstract available

  109. JORGENSEN T, Jacobsen RK, Saebye D, Petersen MW, et al
    Lipid metabolism and functional somatic disorders in the general population. The DanFunD study.
    PLoS One. 2024;19:e0296799.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;